Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Hainan Tianwang International Pharmaceutical is a comprehensive pharmaceutical enterprise based in Haikou, Hainan Province, China. Founded in 1992, the company focuses on the research, development, and large-scale production of chemical drugs across several therapeutic areas, including anti-infectives, cardiovascular health, and respiratory medicine. Its manufacturing facilities are GMP-certified and equipped to produce multiple dosage forms such as tablets, capsules, and granules. The company is recognized as a high-tech enterprise in Hainan and maintains a significant presence in the domestic Chinese generic drug market. Its product portfolio includes widely used medications such as azithromycin, cefixime, and various cold and flu formulations. The firm operates with a focus on providing high-quality, affordable essential medicines to the healthcare system in China.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Hainan Tianwang International Pharmaceutical.